Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Wipro Lt 559.50 3.82
Tata Stl 458.95 0.40
Tata Pow 88.00 0.28
Ong Corp 403.25 0.80
Hindalco 149.65 0.81
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Biocon Limited
Biocon Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
BSE:532523NSE:BIOCONBloomberg:BIOS@INReuters:BION.BO
Market Lot: 1Face Value: 5ISIN Demat: INE376G01013
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
22-OCT-14 Biocon announced a decline in consolidated net profit for the quarter ended September 2014. During the quarter, the profit of the company declined 0.10% to Rs 1,021.00 million from Rs 1,022.00 million in the same quarter previous year. 08-OCT-14 Foreign institutional investors (FIIs) have reduced shareholding in Biocon over the last three months. FIIs' shareholding decreased by 98 basis points to 13.05 percent at the end of September...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Biocon shares rally after selling 10% stake in Syngene  -IRIS 19-Sep-14
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)30-Jun-2014(3)31-Mar-2014 (12)31-Mar-2013 (12)
Net sales 5346.0020980.7018374.80
Other Income117.40605.80514.70
Total Income5463.4021586.5018889.50
Cost of goods sold4422.9017292.4015323.10
OPBDIT1040.504294.103566.40
PAT746.303298.502757.00
Gross Block---
Equity capital1000.001000.001000.00
EPS (Rs.)-16.5314.08
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-16.00 - 30.0914.78 - 22.83
Debt / Equity (x)---
Operating margin (% of OI)19.019.918.9
Net margin (% of OI)13.715.314.6
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
20th KM, Hosur Road
Electronics City Post Office
Bangalore
Karnataka-560 100
PHONE
(080) 2808 2808/ 3037
FAX
(080) 2852 3423
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer